PRJNA522801 - Tumor intrinsic PRMT5 inhibition through MTAP loss predicts response to the first-in-class type I PRMT inhibitor, GSK3368715 - OmicsDI

Genomics

Dataset Information

Tumor intrinsic PRMT5 inhibition through MTAP loss predicts response to the first-in-class type I PRMT inhibitor, GSK3368715

ABSTRACT: Tumor intrinsic PRMT5 inhibition through MTAP loss predicts response to the first-in-class type I PRMT inhibitor, GSK3368715

PROVIDER: PRJNA522801 | ENA |

REPOSITORIES: ENA

Dataset's files

Source:

			Action	DRS
	SRR8582910_1.fastq.gz	Fastqsanger.gz
	SRR8582910_2.fastq.gz	Fastqsanger.gz
	SRR8582920_1.fastq.gz	Fastqsanger.gz
	SRR8582920_2.fastq.gz	Fastqsanger.gz
	SRR8582930_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 64

Similar Datasets